Bodd secures AUD $15 million to drive global 3D scanning growth
Bodd has raised AUD $15 million in new funding, increasing its valuation to AUD $110 million. US-based Blue Sky Capital led the investment round. Ellerston Capital also participated. The round was oversubscribed by 50 percent after strong interest from investors.
Bodd, headquartered in Melbourne, provides 3D body scanning technology. The company collects detailed human body data for commercial and healthcare markets. It has delivered this capital raising to support international expansion and product development.
Investment and growth
Bodd originally planned to raise AUD $10 million. The company increased this to AUD $15 million due to investor demand. Existing shareholders, including Chairman Tim Allison, Non-Executive Director Peter Leonard, John Gerahty's Liangrove Group, Ken Loughnan, and fashion retailers Nick and Candice Hirons, reinvested in the round.
Bodd will use the funds to establish a physical presence in the US. The company plans to expand its customer base in aviation, defence, and healthcare sectors. Bodd recently signed a contract with United Airlines. It is also growing in the UK and Middle East with deployments in law enforcement, emergency services, and aviation.
Bodd will also invest in its healthtech business. The company is preparing for deployments in Australian pharmacies in 2026. These deployments aim to address increasing demand for GLP-1 treatments.
Global demand
Bodd's technology generates high-volume body data in 60 seconds. Its systems are deployed in sectors such as defence, aviation, healthcare, and retail. The company's scanning technology provides private and non-intrusive measurement experiences for users.
Customers include United Airlines, Brooks Brothers, Australian Defence Apparel, and New Zealand Defence Force. Bodd's hardware is manufactured in Melbourne in collaboration with Bosch.
Bodd said that it manages data in compliance with privacy and security requirements of each market.
Investor view
Blue Sky Capital is a major investor in artificial intelligence and data-centre infrastructure. The firm holds a significant position in N-Scale, a UK AI infrastructure company.
Bodd's management said the strong backing from investors supports its strategy.
"We're very humbled by the depth of investor support behind this capital raise, welcoming new investors, and seeing continued backing from so many of our existing investors," said Rob Fisher, Co-Founder and Chief Executive, Bodd.
Fisher said the data industry is seeing rapid change due to artificial intelligence. Bodd's latest funding is part of its plan to scale up activities in sectors with global demand.
"The next stage of global scale for us is truly exciting. We're accelerating our growth in defence, aviation and healthcare, three sectors with sustained global demand. We have new features, new customers and new talent ahead of us," said Fisher.
Blue Sky Capital highlighted Bodd's strategic importance in the data sector.
"Bodd operates in a strategically important position slightly downstream from the infrastructure N-Scale builds. Bodd's high-fidelity body scans have enormous propensity to drive global efficiencies at both a precise and population level," said Steve Bellotti, Blue Sky Capital.
Bodd was founded in 2016 in Melbourne by Rob Fisher and David McLaughlin. The company operates across Asia-Pacific, Europe, the Middle East, and North America. Its products provide detailed sizing and body analysis for multiple industries. Bodd will roll out new health technology services in Australian pharmacies in 2026.